BLACK WEEKSФлакони −15% · комплекти −10% · останалото −5%с кодБезплатна доставка в Германия от 200 €

Тази страница е преведена автоматично и може да съдържа грешки. Български ли е родният Ви език? Ще се радваме на Вашите отзиви и корекции.Изпратете отзив

The Peptide Desk The Peptide Desk
ARA-290, снимка на продукта
Healing

ARA-290

Healing

  • Изпраща се от Германия

Поръчка

Единична цена - Безплатна доставка в Германия над 200 € по време на Black Weeks
  • DHL с проследяване
  • Дискретна опаковка

4.6 от 5 в Trustpilot73 отзива

Накратко

ARA-290 в цифри

Ключовите стойности от нашия лексикон.

Пълна статия в лексикона
Class
EPO-derived peptidenon-hematopoietic
Half-life
short
Use
Subcutaneousin mg
Sizes
10 to 16 mg2 sizes in the shop

Знания

Всичко за ARA-290

Добре е да имате

Какво Ви трябва към него

Бактериостатичната вода се добавя автоматично в количката. Спринцовки и тампони с едно щракване.

Инсулинови спринцовки

10 бр. · 5.50 €

Спиртни тампони

50 бр. · 10 €

Колко вода?

Единици на спринцовката за размера на Вашия флакон.

Отвори калкулатора →

FAQ

Често задавани въпроси

Източници за всеки отговор: статия в лексикона

Още въпроси?

Пишете ни, нашият екип ще Ви помогне.

What is ARA-290?

A small peptide with the drug name cibinetide, designed from the structure of erythropoietin. Unlike EPO it is meant not to make the body form red blood cells. It acts through the innate repair receptor, a complex of the EPO receptor and CD131.

What do the sarcoidosis studies show?

In the first pilot study with 22 participants the symptom score fell by 11.5 points after 4 weeks versus 2.9 with placebo. A second study with daily dosing under the skin for 28 days found fewer symptoms, more nerve fibres in the cornea and a longer walking distance. In the phase 2b trial with 64 participants only the middle study dose was significant.

What about type 2 diabetes?

In a phase 2 trial with daily dosing under the skin for 28 days long-term blood sugar and blood lipids improved over 56 days and so did nerve pain symptoms. In participants with clearly reduced corneal nerve fibre density this density increased, with placebo it did not.

Does ARA-290 help with eye diseases?

In diabetic macular oedema a small study with 9 participants showed no improvement in visual acuity or retinal thickness after 12 weeks. Only the visual function questionnaire came out slightly better. The trial ended early because the study drug expired.

Does ARA-290 affect mood?

In a study with 36 healthy people the brain responded more weakly to happy faces one week after dosing and attention to positive pictures increased. ARA-290 had no effect on mood or emotional state. A clear antidepressant-like profile did not emerge.

Which side effects are known?

No safety concerns appeared in the studies. In diabetic macular oedema there were no serious side effects and no antibodies against the compound after 12 weeks. The abstracts give no percentages for individual side effects.

Свързани

Подобни продукти